Axim Biotechnologies Inc   (AXIM)
Other Ticker:  


Axim Biotechnologies Inc

AXIM's Financial Statements and Analysis

Axim Biotechnologies Inc narrowed III. Quarter net loss per share of $-0.01 compare to net loss per share of $-0.02 recorded in the same quarter a year ago a decrease compare to $-0.01 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.01 $  0 Mill
$+0.01     Unch.     -83.83 %

Axim Biotechnologies Inc 's Revenue fell by -83.83 % in III. Quarter (Sep 30 2022) year on year, to $0 million and advanced by sequentially.

Axim Biotechnologies Inc is Expected to report next financial results on April 18, 2023.

More on AXIM's Income Statement

Axim Biotechnologies Inc 's in III. Quarter recorded net loss of $-2.035 million, an improvement compare to net loss of $-3.292 million in III. Quarter a year ago.

Sequentially net loss advanced

More on AXIM's Growth

Inventories declined by -0.19 % to $0.02 million from III. Quarter a year ago, sequentially inventories fell by 0 %. AXIM's Cash flow In III. Quarter company's net cash flow was $0 million, capital expenditures fell by